{{$t('illness_title')}}
{{$t('report_score')}}
{{$t('report_result')}}
{{item.diseasename}}
{{$t('report_detail')}}
{{$t('health_advice')}}
{{$t('report_explain')}}
Data source:
【1】Guideline for the prevention and treatment of type 2 diabetes mellitus in China(2020 edition)(Part 1) [J]. Chinese Journal of Practical Internal Medicine, 2021, 41 (08): 668-695. DOI:10.19538/j.nk2021080106.
【2】Guideline for the prevention and treatment of type 2 diabetes mellitus in China(2020 edition)(Part 2) [J]. Chinese Journal of Practical Internal Medicine, 2021, 41 (09): 757-784. DOI:10.19538/j.nk2021090106.
【3】Yang X, Li J, Hu D, Chen J, Li Y, Huang J, Liu X, Liu F, Cao J, Shen C, Yu L, Lu F, Wu X, Zhao L, Wu X and Gu Dongfeng. Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China). Circulation. 2016;134:1430-40.